Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1982-12-16
|
pubmed:abstractText |
A series of analogues of dopamine (DA) with varying degrees of conformational flexibility have been examined as potential substrates or competitive inhibitors of the enzyme norepinephrine N-methyltransferase (NMT). A conformationally defined (rigid) analogue of the fully extended conformation of DA, 2-amino-6,7-dihydroxybenzonorbornene hydrobromide (3; 6,7-D2HX) proved to be a better substrate than the non-catechol parent 2-aminobenzonorbornene (4; 2HX). However, analogues 3 and 4 displayed equivalent competitive inhibitory activity toward phenylethanolamine (PEA). Neither 6,7-ADTN (5), a DA analogue in the 2-aminotetralin (2AT) system, nor 6,7-DTHIQ (7), a DA analogue in the tetrahydroisoquinoline (THIQ) system, showed substrate activity; 6,7-ADTN was a poorer competitive inhibitor than the parent 2AT but 6,7-DTHIQ was a better competitive inhibitor than its parent, THIQ (8). A tricyclic conformationally defined analogue 9 of 6,7-ADTN was devoid of either substrate or inhibitory activity. From these results it may be concluded that a fully extended side chain conformation is required for NMT substrate activity, and the better substrate activity for 6,7-D2HX compared to 4 is consistent with a proper catechol orientation for interaction with the norepinephrine (NE) binding site of NMT.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
993-1000
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7132559-Adrenal Glands,
pubmed-meshheading:7132559-Animals,
pubmed-meshheading:7132559-Cattle,
pubmed-meshheading:7132559-Dopamine,
pubmed-meshheading:7132559-Kinetics,
pubmed-meshheading:7132559-Molecular Conformation,
pubmed-meshheading:7132559-Phenylethanolamine N-Methyltransferase,
pubmed-meshheading:7132559-Structure-Activity Relationship,
pubmed-meshheading:7132559-Substrate Specificity
|
pubmed:year |
1982
|
pubmed:articleTitle |
Conformational preferences of dopamine analogues for inhibition of norepinephrine N-methyltransferase. Conformationally defined adrenergic agents.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|